Skip to main content
. Author manuscript; available in PMC: 2019 Sep 20.
Published in final edited form as: J Manag Care Spec Pharm. 2019 Feb;25(2):195–210. doi: 10.18553/jmcp.2019.25.2.195

FIGURE 1. Six-Month Drug Costs for CHC Treatment Across Years.

FIGURE 1

aP < 0.001 for the nonparametric Kruskal-Wallis test.

CHC = chronic hepatitis C; LED = ledipasvir; PEG = peginterferon alfa-2a or peginterferon alfa-2b; RBV = ribavirin; SIM=simeprevir; SOF = sofosbuvir.